SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Acadia Pharmaceuticals Inc. & a...
April 21 2015 - 10:43AM
Business Wire
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the Southern District of
California on behalf of investors who purchased ACADIA
Pharmaceuticals Inc. (“ACADIA” or the “Company”) (NasdaqGS: ACAD)
securities between February 26, 2015 and March 11, 2015.
Click here to learn about the case:
http://docs.wongesq.com/ACAD-Info-Request-Form-673. There is
no cost or obligation to you.
The complaint alleges that the Company made false and misleading
statements and/or failed to disclose material information regarding
the timing of its submission of its New Drug Application to the FDA
for Nuplazid.
On March 11, 2015, the Company announced it would delay
submitting a New Drug Application for its drug Nuplazid. The
Company also noted that Chief Executive Officer Uli Hacksell is
retiring. Shares of ACADIA were down more than 20% on intraday
trading the following day.
If you suffered a loss in ACADIA you have until May 12, 2015 to
request that the Court appoint you as lead plaintiff. Your ability
to share in any recovery doesn’t require that you serve as a lead
plaintiff. To obtain additional information, contact Vincent Wong,
Esq. either via email vw@wongesq.com, by telephone at 212.425.1140,
or visit
http://docs.wongesq.com/ACAD-Info-Request-Form-673.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights. Attorney advertising.
Prior results do not guarantee similar outcomes.
The Law Offices of Vincent WongVincent Wong, Esq.,
212.425.1140Fax. 866.699.3880vw@wongesq.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Apr 2023 to Apr 2024